Effectiveness of a ‘lung age’ intervention on smoking cessation rate in a Singaporean community

A pilot randomised controlled trial on the effectiveness of a ‘lung age’ intervention on smoking cessation rate in a Singaporean community

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN11953002

Enrollment

108

Registered

2015-02-26

Start date

2014-11-01

Completion date

Unknown

Last updated

2022-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation Mental and Behavioural Disorders Smoking cessation

Interventions

A convenience sample of 108 participants will be recruited from population health screenings conducted by a tertiary public hospital in Singapore with 54 participants in the experimental group and 54

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Currently smoking 2. Aged 35 years old and above 3. Able to read and/or speak in English and/or Mandarin

Exclusion criteria

Exclusion criteria: 1. Have a known history of major psychiatric illness 2. History of Respiratory related diseases: COPD, asthma, bronchioectasis 3. Ejection fraction <40 %, or diagnosed with congestive cardiac failure 4. Diagnosed with acute myocardial infarction within 1 month 5. Diagnosed with fluid overload / acute pulmonary oedema 6. Receiving oxygen therapy 7, Recent eye/thoracic/abdominal surgery 8. Chest/abdominal/oral and facial pain 9. Hyperventilation syndrome

Design outcomes

Primary

Measure	Time frame
1. To explore the feasibility of applying the “lung age” intervention among the smoking community in Singapore. 2. To evaluate the effectiveness of the “lung age’ intervention on smoking cessation rates, smoking abstinence self-efficacy and nicotine dependence and among this group of population. Data will be collected at the baseline and again at the third and sixth month follow-ups. Data will be analysed using IBM SPSS 22.	—

Measure

Time frame

1. To explore the feasibility of applying the “lung age” intervention among the smoking community in Singapore. 2. To evaluate the effectiveness of the “lung age’ intervention on smoking cessation rates, smoking abstinence self-efficacy and nicotine dependence and among this group of population. Data will be collected at the baseline and again at the third and sixth month follow-ups. Data will be analysed using IBM SPSS 22.

—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

Singapore

Contacts

Public ContactImran Muhammad

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026